PR Newswire - Roxane Laboratories, Inc. Announces the Launch of Ramipril Capsules
Tuesday, November 11th, 2008COLUMBUS, Ohio, June 18 /PRNewswire/ — Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Ramipril Capsules, 1.25mg, 2.5mg, 5mg and 10mg by the U.S. Food and Drug Administration. The 1.25mg, 2.5mg, 5mg and 10mg strengths will be available in various packaging configurations. Roxane Laboratories Rami…
